Basic Information
ADEL is a leading-edge technology company specializing in the treatment and diagnosis of neurological diseases, including Alzheimer's disease. Founded by scientists researching Alzheimer's disease at the Asan Medical Center, Ulsan University School of Medicine in South Korea, ADEL is developing smart, innovative drug candidates for patients worldwide.
ADEL, Inc.
Seoul,SeoulSpecialCity,SouthKorea
unclear
January 01, 2016
adel@adelpharm.com

